Myelofibrosis

Myelofibrosis is a bone marrow disorder in which scarring can interfere with normal blood-cell production.

When the marrow cannot work normally, the body may try to make blood cells elsewhere, particularly in the spleen. Myelofibrosis belongs to a group of blood disorders called myeloproliferative neoplasms.

Abdominal swelling is a common presentation of myelofibrosis and may reflect an enlarged spleen. Night sweats are another common presentation. Some people first learn about the condition after an abnormal blood test and have few noticeable symptoms.

Tiredness, breathlessness, early fullness after eating, bone discomfort, fever, itching or unplanned weight change can occur. Sudden severe abdominal pain, chest pain, new weakness or unusual bleeding needs urgent assessment.

Changes within blood-forming cells can make the marrow produce cells in an abnormal way and lead to fibrosis, or scarring. These changes are acquired during life; myelofibrosis is not spread between people. It may arise on its own or develop after another myeloproliferative disorder.

The condition can follow different paths. Regular reviews show whether blood counts, spleen symptoms or general wellbeing are changing. The team uses this information to decide when observation remains appropriate and when treatment may offer useful symptom control or disease management.

Myelofibrosis is more often diagnosed later in adulthood. A history of essential thrombocythaemia or polycythaemia vera can be relevant because myelofibrosis can sometimes follow these conditions. Most people with these conditions do not automatically develop myelofibrosis.

Assessment often starts with a full blood count and examination of the abdomen for spleen enlargement. Blood tests, a bone marrow sample and genetic testing can clarify the diagnosis. Imaging may help the team assess the spleen and other organs when symptoms suggest enlargement.

Care is tailored to symptoms, blood counts, spleen size, genetic findings and overall fitness. Targeted therapy may be used to ease troublesome symptoms or control disease activity. Transfusions and medicines for anaemia may be discussed when red-cell levels are low. An allogeneic stem cell transplant is an intensive option considered for selected people after a detailed discussion of suitability and risks.

Track symptoms between visits, including energy, appetite, sweating and abdominal discomfort. Avoid starting supplements or pain medicines without checking with the team, since some can affect bleeding or interact with treatment. A dietitian, nurse specialist or counsellor can help with practical concerns.

Low blood counts can raise the chance of fatigue, infections or bleeding. An enlarged spleen can create discomfort or early fullness. Tell the clinical team promptly about fever, bleeding, a major change in abdominal pain or a new decline in daily function.